KRYS
Krystal Biotech, Inc.
Company overview
- Market capitalization
- $9.98B
- Employees
- 295
- Latest publication
- 2026-09-29
About Krystal Biotech, Inc.
Krystal Biotech, Inc., a commercial-stage biotechnology company, discovers, develops, manufactures, and commercializes genetic medicines to treat diseases with high unmet medical needs in the United States. The company commercializes VYJUVEK (beremagene geperpavec-svdt, or B-VEC) for the treatment of dystrophic epidermolysis bullosa (DEB). It also develops KB803 for ocular complications of dystrophic epidermolysis bullosa; KB801 for neurotrophic keratitis; KB407, which is in Phase 1 clinical trials for treating cystic fibrosis; KB111 for Hailey-Hailey disease; KB707 for solid tumors; KB304 for dynamic wrinkles; KB707 that is in Phase 1/2 clinical trials for the treatment of anti-PD-1 relapsed/refractory; KB408, which is in Phase 1 clinical trials for treating Alpha-1 antitrypsin deficiency; and KB301 that is in Phase 2 clinical trials for treating aesthetic skin conditions, as well as in open label study with ophthalmic B-VEC for treating for ocular complications of deb. Krystal Biotech, Inc. was founded in 2016 and is headquartered in Pittsburgh, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 119,222,000USD | 116,357,000USD | 107,105,000USD | 97,800,000USD | 96,042,000USD | 88,183,000USD | 91,139,000USD | 83,841,000USD |
| Research Development | 14,518,000USD | 15,331,000USD | 16,195,000USD | 13,185,000USD | 14,410,000USD | 14,255,000USD | 13,523,000USD | 13,511,000USD |
| Selling General Administrative | 39,850,000USD | 41,014,000USD | 41,449,000USD | 37,578,000USD | 35,160,000USD | 32,723,000USD | 31,288,000USD | 28,713,000USD |
| Total Operating Expenses | 60,805,000USD | 56,345,000USD | 51,751,000USD | 50,763,000USD | 49,570,000USD | 46,978,000USD | 44,811,000USD | 54,724,000USD |
| Operating Income | 58,417,000USD | 53,689,000USD | 44,437,000USD | 41,374,000USD | 39,307,000USD | 36,177,000USD | 41,379,000USD | 22,433,000USD |
| Total Other Income Expense Net | 7,662,000USD | 7,753,000USD | 6,695,000USD | 6,593,000USD | 7,468,000USD | 7,420,000USD | 7,231,000USD | 7,336,000USD |
| Income Before Tax | 66,079,000USD | 61,442,000USD | 51,132,000USD | 47,967,000USD | 46,775,000USD | 43,597,000USD | 48,610,000USD | 29,769,000USD |
| Income Tax Expense | 11,311,000USD | 5,510,000USD | -268,000USD | -31,398,000USD | 8,442,000USD | 7,864,000USD | 3,131,000USD | 2,589,000USD |
| Net Income | 54,768,000USD | 55,932,000USD | 51,400,000USD | 79,365,000USD | 38,333,000USD | 35,733,000USD | 45,479,000USD | 27,180,000USD |
| Cost Of Revenue | 6,437,000USD | 6,323,000USD | 10,917,000USD | 5,663,000USD | 7,165,000USD | 5,028,000USD | 4,949,000USD | 6,684,000USD |
| Gross Profit | — | 110,034,000USD | 96,188,000USD | 92,137,000USD | 88,877,000USD | 83,155,000USD | 86,190,000USD | 77,157,000USD |
| Net Interest Income | — | 7,753,000USD | 6,861,000USD | 6,593,000USD | 7,468,000USD | 7,420,000USD | 7,231,000USD | 7,336,000USD |
| Tax Provision | — | 5,510,000USD | -269,000USD | -31,398,000USD | 8,442,000USD | 7,864,000USD | 3,131,000USD | 2,589,000USD |
| Net Income From Continuing Ops | — | 55,932,000USD | 51,400,000USD | 79,365,000USD | 38,333,000USD | 35,733,000USD | 45,479,000USD | 27,180,000USD |
| Ebit | — | 61,442,000USD | 37,844,000USD | 47,967,000USD | 46,775,000USD | 43,597,000USD | 48,610,000USD | 34,933,000USD |
| Ebitda | — | 63,168,000USD | 39,609,000USD | 49,576,000USD | 48,318,000USD | 45,231,000USD | 50,165,000USD | 36,462,000USD |
| Depreciation And Amortization | — | 1,726,000USD | 1,765,000USD | 1,609,000USD | 1,543,000USD | 1,634,000USD | 1,555,000USD | 1,529,000USD |
| Reconciled Depreciation | — | 1,726,000USD | 1,762,000USD | 1,612,000USD | 1,543,000USD | 1,634,000USD | 1,555,000USD | 1,529,000USD |
| Unclassified Operating Expenses | — | — | -5,893,000USD | — | — | — | — | 12,500,000USD |
| Interest Income | — | — | 6,861,000USD | 6,593,000USD | 7,468,000USD | — | — | 7,297,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD | FY 20172017-12-31 · USD | FY 20162016-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 389,130,000USD | 290,515,000USD | 0USD | 1,027,000USD | 0USD | 0USD |
| Cost Of Revenue | 28,773,000USD | 20,061,000USD | 974,000USD | 141,000USD | 23,000USD | 2,000USD |
| Gross Profit | 360,357,000USD | 270,454,000USD | -974,000USD | 886,000USD | -23,000USD | -2,000USD |
| Research Development | 58,045,000USD | 53,573,000USD | 15,616,000USD | 7,761,000USD | 3,208,000USD | 741,000USD |
| Selling General Administrative | 146,741,000USD | 113,686,000USD | 6,465,000USD | 4,155,000USD | 1,564,000USD | 402,000USD |
| Unclassified Operating Expenses | -5,724,000USD | 37,500,000USD | — | — | — | — |
| Total Operating Expenses | 199,062,000USD | 204,759,000USD | 22,081,000USD | 11,916,000USD | 4,772,000USD | 1,143,000USD |
| Operating Income | 161,295,000USD | 65,695,000USD | -22,081,000USD | -11,916,000USD | -4,772,000USD | -1,143,000USD |
| Interest Income | 28,176,000USD | 29,661,000USD | 2,993,000USD | 1,027,000USD | 3,148,000USD | 7,000USD |
| Net Interest Income | 28,176,000USD | 29,661,000USD | 2,993,000USD | 1,027,000USD | -3,148,000USD | -7,000USD |
| Income Before Tax | 189,471,000USD | 95,356,000USD | -19,088,000USD | -10,889,000USD | -7,920,000USD | -1,150,000USD |
| Income Tax Expense | -15,360,000USD | 6,197,000USD | 576,140USD | -20,141USD | 0USD | 0USD |
| Tax Provision | -15,360,000USD | 6,197,000USD | — | — | — | — |
| Net Income | 204,831,000USD | 89,159,000USD | -19,088,000USD | -10,889,000USD | -7,920,000USD | -1,150,000USD |
| Net Income From Continuing Ops | 204,831,000USD | 89,159,000USD | -19,088,000USD | -10,889,000USD | -7,920,000USD | -1,150,000USD |
| Ebit | 189,471,000USD | 103,195,000USD | -19,088,000USD | -10,889,000USD | -4,657,000USD | -1,143,000USD |
| Ebitda | 196,022,000USD | 109,909,000USD | -18,114,000USD | -10,748,000USD | -4,634,000USD | -1,141,000USD |
| Depreciation And Amortization | 6,551,000USD | 6,714,000USD | 974,000USD | 141,000USD | 23,000USD | 2,000USD |
| Reconciled Depreciation | 6,551,000USD | 6,714,000USD | 748,000USD | 141,000USD | 23,000USD | — |
| Total Other Income Expense Net | 28,176,000USD | 29,661,000USD | 2,993,000USD | 1,027,000USD | -3,148,000USD | -7,000USD |
| Interest Expense | — | — | 0USD | 1,027,000USD | 3,148,000USD | 7,000USD |
| Net Income Applicable To Common Shares | — | — | -19,088,000USD | -10,889,000USD | -7,920,000USD | -1,150,000USD |
| Non Operating Income Net Other | — | — | — | — | -3,148,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,500,648,000USD | 1,396,967,000USD | 1,333,794,000USD | 1,240,094,000USD | 1,138,394,000USD | 1,074,416,000USD | 1,055,838,000USD | 982,318,000USD |
| Cash And Equivalents | 427,740,000USD | — | — | — | — | — | — | — |
| Cash And Short Term Investments | 845,600,000USD | 823,405,000USD | 827,791,000USD | 731,069,000USD | 681,986,000USD | 616,846,000USD | 597,517,000USD | 588,324,000USD |
| Long Term Investments | 257,291,000USD | 193,485,000USD | 128,066,000USD | 133,113,000USD | 138,807,000USD | 148,472,000USD | 152,114,000USD | 105,888,000USD |
| Total Current Assets | 1,059,648,000USD | 1,019,741,000USD | 1,024,602,000USD | 925,650,000USD | 841,347,000USD | 766,798,000USD | 742,045,000USD | 713,164,000USD |
| Other Current Assets | 14,491,000USD | 26,668,000USD | 28,911,000USD | 27,316,000USD | 16,881,000USD | 16,750,000USD | 13,274,000USD | 8,961,000USD |
| Other Non Current Assets | 284,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 141,522,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 127,397,000USD | 107,802,000USD | 102,942,000USD | 91,268,000USD | 86,896,000USD | 79,489,000USD | 101,995,000USD | 89,527,000USD |
| Other Current Liabilities | 3,428,000USD | — | — | — | — | — | — | — |
| Other Non Current Liabilities | 7,080,000USD | — | — | — | — | — | — | — |
| Total Stockholder Equity | 1,359,126,000USD | 1,276,729,000USD | 1,219,560,000USD | 1,137,876,000USD | 1,040,647,000USD | 984,674,000USD | 946,380,000USD | 885,846,000USD |
| Total Equity Including Noncontrolling Interest | 1,359,126,000USD | — | — | — | — | — | — | — |
| Net Receivables | 138,662,000USD | 127,022,000USD | 127,425,000USD | 129,633,000USD | 111,439,000USD | 103,260,000USD | 104,746,000USD | 97,298,000USD |
| Inventory | 45,556,000USD | 42,646,000USD | 40,475,000USD | 37,632,000USD | 31,041,000USD | 29,942,000USD | 26,508,000USD | 18,581,000USD |
| Property Plant Equipment Net | 160,601,000USD | 160,617,000USD | 158,015,000USD | 156,318,000USD | 158,043,000USD | 158,928,000USD | 161,448,000USD | 163,063,000USD |
| Accounts Payable | 6,544,000USD | 4,089,000USD | 3,238,000USD | 2,097,000USD | 7,124,000USD | 2,672,000USD | 4,985,000USD | 5,580,000USD |
| Short Term Debt | 1,808,000USD | 1,800,000USD | 1,771,000USD | 1,698,000USD | 1,617,000USD | 1,362,000USD | 1,217,000USD | 1,292,000USD |
| Common Stock | 0USD | — | — | — | — | — | — | — |
| Retained Earnings | 134,863,000USD | 80,095,000USD | 24,163,000USD | -27,237,000USD | -106,602,000USD | -144,935,000USD | -180,668,000USD | -226,147,000USD |
| Accumulated Other Comprehensive Income | -4,335,000USD | -1,623,000USD | 1,136,000USD | 1,100,000USD | 1,157,000USD | 390,000USD | -190,000USD | 1,512,000USD |
| Total Liab | — | 120,238,000USD | 114,234,000USD | 102,218,000USD | 97,747,000USD | 89,742,000USD | 109,458,000USD | 96,472,000USD |
| Other Current Liab | — | 101,913,000USD | 97,933,000USD | 87,473,000USD | 69,857,000USD | 64,026,000USD | 91,505,000USD | 82,082,000USD |
| Capital Stock | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cash | — | 501,313,000USD | 496,304,000USD | 392,604,000USD | 353,829,000USD | 308,770,000USD | 344,865,000USD | 373,966,000USD |
| Net Debt | — | -492,201,000USD | -486,965,000USD | -383,093,000USD | -344,148,000USD | -299,108,000USD | -337,604,000USD | -366,490,000USD |
| Short Long Term Debt Total | — | 9,112,000USD | 9,339,000USD | 9,511,000USD | 9,681,000USD | 9,662,000USD | 7,261,000USD | 7,476,000USD |
| Short Term Investments | — | 322,092,000USD | 331,487,000USD | 338,465,000USD | 328,157,000USD | 308,076,000USD | 252,652,000USD | 214,358,000USD |
| Property Plant Equipment Gross | — | 194,389,000USD | 189,296,000USD | 185,490,000USD | 184,699,000USD | 183,201,000USD | 183,367,000USD | 182,854,000USD |
| Common Stock Shares Outstanding | — | 30,507,000shares | 29,951,000shares | 29,833,000shares | 29,749,000shares | 29,871,000shares | 29,883,000shares | 29,902,000shares |
| Non Current Assets Total | — | 377,226,000USD | 309,192,000USD | 314,444,000USD | 297,047,000USD | 307,618,000USD | 313,793,000USD | 269,154,000USD |
| Non Current Liabilities Total | — | 12,436,000USD | 11,292,000USD | 10,950,000USD | 10,851,000USD | 10,253,000USD | 7,463,000USD | 6,945,000USD |
| Non Current Liabilities Other | — | 5,124,000USD | 3,724,000USD | 3,137,000USD | 2,787,000USD | 1,953,000USD | 1,419,000USD | — |
| Non Currrent Assets Other | — | 300,000USD | 287,000USD | 333,000USD | 197,000USD | 218,000USD | 231,000USD | 203,000USD |
| Net Working Capital | — | 911,939,000USD | 921,660,000USD | 834,382,000USD | 754,451,000USD | 687,309,000USD | 640,050,000USD | 623,637,000USD |
| Unclassified Non Current Assets | — | 22,824,000USD | 22,824,000USD | 24,680,000USD | — | — | — | — |
| Unclassified Non Current Liabilities | — | 7,312,000USD | 7,568,000USD | 7,813,000USD | 8,064,000USD | 8,300,000USD | 6,044,000USD | 6,945,000USD |
| Unclassified Equity | — | 1,198,257,000USD | 1,194,261,000USD | 1,164,013,000USD | 1,146,092,000USD | 1,129,219,000USD | 1,127,238,000USD | 1,110,481,000USD |
| Unclassified Current Liabilities | — | — | — | — | 8,298,000USD | 11,429,000USD | 4,288,000USD | — |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 1,333,794,000USD | 1,055,838,000USD | 818,355,000USD | 558,450,000USD | 626,295,000USD | 310,844,000USD | 209,023,000USD | 116,116,000USD |
| Other Current Assets | 28,911,000USD | 13,274,000USD | 6,706,000USD | 4,608,000USD | 4,171,000USD | 3,796,000USD | 2,195,000USD | 889,000USD |
| Total Liab | 114,234,000USD | 109,458,000USD | 39,714,000USD | 36,219,000USD | 32,719,000USD | 18,760,000USD | 6,109,000USD | 2,890,000USD |
| Total Stockholder Equity | 1,219,560,000USD | 946,380,000USD | 778,641,000USD | 522,231,000USD | 593,576,000USD | 292,084,000USD | 202,914,000USD | 113,226,000USD |
| Other Current Liab | 97,933,000USD | 91,505,000USD | 27,488,000USD | 23,262,000USD | 16,214,000USD | 5,069,000USD | 1,786,000USD | 1,554,000USD |
| Capital Stock | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Retained Earnings | 24,163,000USD | -180,668,000USD | -269,827,000USD | -280,759,000USD | -140,784,000USD | -71,214,000USD | -39,047,000USD | -19,959,000USD |
| Cash | 496,304,000USD | 344,865,000USD | 358,328,000USD | 161,900,000USD | 341,246,000USD | 268,269,000USD | 187,514,000USD | 103,670,000USD |
| Cash And Short Term Investments | 827,791,000USD | 597,517,000USD | 532,178,000USD | 379,171,000USD | 438,096,000USD | 271,262,000USD | 193,685,000USD | 111,761,000USD |
| Total Current Assets | 1,024,602,000USD | 742,045,000USD | 587,909,000USD | 383,779,000USD | 442,267,000USD | 275,058,000USD | 195,880,000USD | 112,650,000USD |
| Total Current Liabilities | 102,942,000USD | 101,995,000USD | 33,094,000USD | 28,847,000USD | 25,736,000USD | 15,452,000USD | 3,327,000USD | 2,596,000USD |
| Net Debt | -486,965,000USD | -337,604,000USD | -350,234,000USD | -152,967,000USD | -333,222,000USD | -256,723,000USD | -184,252,000USD | -103,670,000USD |
| Short Term Debt | 1,771,000USD | 1,217,000USD | 1,474,000USD | 1,561,000USD | 1,041,000USD | 8,238,000USD | 480,000USD | — |
| Short Long Term Debt Total | 9,339,000USD | 7,261,000USD | 8,094,000USD | 8,933,000USD | 8,024,000USD | 11,546,000USD | 3,262,000USD | — |
| Long Term Investments | 128,066,000USD | 152,114,000USD | 61,954,000USD | 4,621,000USD | 64,371,000USD | 0USD | 497,000USD | — |
| Short Term Investments | 331,487,000USD | 252,652,000USD | 173,850,000USD | 217,271,000USD | 96,850,000USD | 2,993,000USD | 6,171,000USD | 8,091,000USD |
| Net Receivables | 127,425,000USD | 104,746,000USD | 42,040,000USD | 0USD | — | — | — | — |
| Inventory | 40,475,000USD | 26,508,000USD | 6,985,000USD | 0USD | — | — | — | — |
| Accounts Payable | 3,238,000USD | 4,985,000USD | 1,849,000USD | 3,981,000USD | 8,398,000USD | 2,105,000USD | 1,021,000USD | 888,000USD |
| Property Plant Equipment Net | 158,015,000USD | 161,448,000USD | 168,229,000USD | 169,726,000USD | 119,583,000USD | 34,174,000USD | 11,184,000USD | 3,014,000USD |
| Property Plant Equipment Gross | 189,296,000USD | 183,367,000USD | 181,056,000USD | 176,519,000USD | 123,797,000USD | 34,174,000USD | 11,184,000USD | 3,014,000USD |
| Accumulated Other Comprehensive Income | 1,136,000USD | -190,000USD | 638,000USD | -728,000USD | -163,000USD | 6,000USD | 10,000USD | 2,000USD |
| Common Stock Shares Outstanding | 29,951,000shares | 29,740,000shares | 27,752,000shares | 25,492,000shares | 22,196,846shares | 18,787,161shares | 15,901,083shares | 11,203,081shares |
| Non Current Assets Total | 309,192,000USD | 313,793,000USD | 230,446,000USD | 174,671,000USD | 184,028,000USD | 35,786,000USD | 13,143,000USD | 3,466,000USD |
| Non Current Liabilities Total | 11,292,000USD | 7,463,000USD | 6,620,000USD | 7,372,000USD | 6,983,000USD | 3,308,000USD | 2,782,000USD | 294,000USD |
| Non Current Liabilities Other | 3,724,000USD | 1,419,000USD | — | — | 6,983,000USD | 3,308,000USD | 2,782,000USD | 294,000USD |
| Non Currrent Assets Other | 287,000USD | 231,000USD | 263,000USD | 324,000USD | 74,000USD | 1,612,000USD | 1,462,000USD | 452,000USD |
| Net Working Capital | 921,660,000USD | 640,050,000USD | 554,815,000USD | 354,932,000USD | 416,531,000USD | 259,606,000USD | 192,553,000USD | 110,054,000USD |
| Unclassified Non Current Assets | 22,824,000USD | — | — | — | — | -4,910,000USD | -1,462,000USD | — |
| Unclassified Non Current Liabilities | 7,568,000USD | 6,044,000USD | 6,620,000USD | 7,372,000USD | — | — | — | — |
| Unclassified Equity | 1,194,261,000USD | 1,127,238,000USD | 1,047,830,000USD | 803,718,000USD | 734,523,000USD | 363,292,000USD | 241,951,000USD | 249,299,000USD |
| Unclassified Current Liabilities | — | 4,288,000USD | 2,283,000USD | — | -16,127,000USD | -5,043,000USD | -2,064,000USD | — |
| Current Deferred Revenue | — | — | -2,283,001USD | — | 16,210,000USD | 5,083,000USD | 2,104,000USD | — |
| Other Assets | — | — | — | 324,000USD | 74,000USD | 4,910,000USD | 1,462,000USD | 452,000USD |
| Net Tangible Assets | — | — | — | 522,231,000USD | 593,576,000USD | 292,084,000USD | 202,914,000USD | 113,226,000USD |
| Common Stock | — | — | — | — | — | — | — | -116,116,000USD |
| Other Liab | — | — | — | — | — | — | — | 294,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow YTD
| Metric | Q2 20262026-06-30 · USD |
|---|---|
| Depreciation | 2,900,000USD |
| Stock Based Compensation | 27,765,000USD |
| Change To Account Receivables | -11,915,000USD |
| Change To Inventory | -1,201,000USD |
| Change To Liabilities | 6,667,000USD |
| Change In Working Capital | -10,929,000USD |
| Operating Cash Flow | 155,171,000USD |
| Capital Expenditures | -10,713,000USD |
| Net Investments | -418,056,000USD |
| Unclassified Investing Cash Flow | 203,602,000USD |
| Investing Cash Flow | -225,167,000USD |
| Financing Cash Flow | 4,594,000USD |
| Effect Of Forex Changes On Cash | -3,162,000USD |
| Change In Cash | -68,564,000USD |
| End Cash Flow | 427,740,000USD |
| Source | DisclosureDeterministicFinal |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 55,932,000USD | 51,400,000USD | 79,365,000USD | 38,334,000USD | 35,733,000USD | 45,479,000USD | 27,179,000USD | 15,569,000USD |
| Depreciation | 1,522,000USD | 1,762,000USD | 1,609,000USD | 1,543,000USD | 1,634,000USD | 1,555,000USD | 1,529,000USD | 2,021,000USD |
| Stock Based Compensation | 13,609,000USD | 13,764,000USD | 13,153,000USD | 14,119,000USD | 13,478,000USD | 13,356,000USD | 13,316,000USD | 13,156,000USD |
| Other Non Cash Items | -4,691,000USD | -752,000USD | 11,242,000USD | -1,761,000USD | -1,341,000USD | -1,886,000USD | -1,363,000USD | -1,621,000USD |
| Change To Account Receivables | 58,000USD | 2,492,000USD | -17,923,000USD | -8,179,000USD | 1,486,000USD | -7,449,000USD | 5,939,000USD | -56,769,000USD |
| Change To Inventory | -243,000USD | -1,058,000USD | -4,713,000USD | 880,000USD | -1,395,000USD | -6,521,000USD | -3,678,000USD | 530,000USD |
| Change In Working Capital | 14,010,000USD | 9,499,000USD | -27,877,000USD | 494,000USD | -18,535,000USD | -5,661,000USD | 18,196,000USD | -33,293,000USD |
| Total Cash From Operating Activities | 80,382,000USD | 77,508,000USD | 39,659,000USD | 52,729,000USD | 30,969,000USD | 52,843,000USD | 58,857,000USD | -4,168,000USD |
| Capital Expenditures | -7,148,000USD | -2,139,000USD | -1,704,000USD | -1,904,000USD | -6,204,000USD | -801,000USD | -1,046,000USD | -1,131,000USD |
| Free Cash Flow | 73,234,000USD | 75,369,000USD | 37,955,000USD | 50,825,000USD | 24,765,000USD | 52,042,000USD | 57,811,000USD | -5,299,000USD |
| Investments | -56,435,000USD | 13,302,000USD | -4,286,000USD | -10,525,000USD | -54,769,000USD | -83,778,000USD | -34,328,000USD | -19,353,000USD |
| Total Cashflows From Investing Activities | -63,583,000USD | 11,163,000USD | -4,286,000USD | -10,525,000USD | -54,769,000USD | -83,778,000USD | -34,328,000USD | -19,353,000USD |
| Total Cash From Financing Activities | -10,459,000USD | 15,666,000USD | 3,709,000USD | 1,796,000USD | -12,466,000USD | 2,428,000USD | 3,365,000USD | 10,638,000USD |
| Sale Purchase Of Stock | -16,960,000USD | — | — | — | — | — | — | — |
| Change In Cash | 5,009,000USD | 103,700,000USD | 38,775,000USD | 45,059,000USD | -36,095,000USD | -29,101,000USD | 28,180,000USD | -13,220,000USD |
| Begin Period Cash Flow | 496,304,000USD | 392,604,000USD | 353,829,000USD | 308,770,000USD | 344,865,000USD | 373,966,000USD | 345,786,000USD | 359,006,000USD |
| End Period Cash Flow | 501,313,000USD | 496,304,000USD | 392,604,000USD | 353,829,000USD | 308,770,000USD | 344,865,000USD | 373,966,000USD | 345,786,000USD |
| Unclassified Financing Cash Flow | 6,501,000USD | 15,689,000USD | 3,714,000USD | — | 1,462,000USD | — | — | — |
| Other Cashflows From Financing Activities | — | -23,000USD | -5,000USD | 1,796,000USD | -13,928,000USD | 2,428,000USD | 3,365,000USD | 10,638,000USD |
| Unclassified Operating Cash Flow | — | 1,835,000USD | -37,833,000USD | — | — | — | — | — |
| Unclassified Investing Cash Flow | — | — | 1,704,000USD | 1,904,000USD | 5,769,000USD | — | 1,046,000USD | 1,131,000USD |
| Other Cashflows From Investing Activities | — | — | — | — | 435,000USD | — | — | — |
| Issuance Of Capital Stock | — | — | — | — | — | 0USD | 0USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | 204,831,000USD | 89,159,000USD | 10,932,000USD | -139,975,000USD | -69,570,000USD | -32,167,000USD | -19,088,000USD | -10,889,000USD |
| Depreciation | 6,551,000USD | 6,714,000USD | 5,007,000USD | 4,055,000USD | 2,769,000USD | 1,851,000USD | 748,000USD | 141,000USD |
| Stock Based Compensation | 54,514,000USD | 49,127,000USD | 39,933,000USD | 33,230,000USD | 15,319,000USD | 3,272,000USD | 1,239,000USD | 792,000USD |
| Other Non Cash Items | -5,767,000USD | -7,123,000USD | -106,794,000USD | -690,000USD | 1,492,000USD | 33,000USD | 67,000USD | 962,000USD |
| Change To Account Receivables | -22,124,000USD | -62,706,000USD | -42,040,000USD | 0USD | 0USD | — | — | — |
| Change To Inventory | -6,286,000USD | -11,907,000USD | -4,475,000USD | 0USD | 0USD | — | — | — |
| Change In Working Capital | -36,419,000USD | -14,457,000USD | -37,882,000USD | 2,811,000USD | 2,052,000USD | 928,000USD | -1,679,000USD | 511,000USD |
| Total Cash From Operating Activities | 200,865,000USD | 123,420,000USD | -88,804,000USD | -100,569,000USD | -47,938,000USD | -26,083,000USD | -18,713,000USD | -9,445,000USD |
| Capital Expenditures | -11,951,000USD | -4,238,000USD | -11,799,000USD | -52,979,000USD | -68,336,000USD | -14,843,000USD | -6,399,000USD | -2,234,000USD |
| Free Cash Flow | 188,914,000USD | 119,182,000USD | -100,603,000USD | -153,548,000USD | -116,274,000USD | -40,926,000USD | -25,112,000USD | -11,679,000USD |
| Investments | -46,901,000USD | -163,439,000USD | 82,638,000USD | -114,083,000USD | -158,434,000USD | 3,662,000USD | 1,431,000USD | -10,323,000USD |
| Total Cashflows From Investing Activities | -58,417,000USD | -163,439,000USD | 82,638,000USD | -114,083,000USD | -226,770,000USD | -11,181,000USD | -4,968,000USD | -10,323,000USD |
| Total Cash From Financing Activities | 8,705,000USD | 27,014,000USD | 202,750,000USD | 35,347,000USD | 347,685,000USD | 118,019,000USD | 107,525,000USD | 73,847,000USD |
| Issuance Of Capital Stock | 0USD | 0USD | 203,499,000USD | 35,996,000USD | 355,645,000USD | 118,019,000USD | 107,525,000USD | 73,847,000USD |
| Change In Cash | 151,439,000USD | -13,463,000USD | 196,428,000USD | -179,346,000USD | 72,977,000USD | 80,755,000USD | 83,844,000USD | 54,079,000USD |
| Begin Period Cash Flow | 344,865,000USD | 358,328,000USD | 161,900,000USD | 341,246,000USD | 268,269,000USD | 187,514,000USD | 103,670,000USD | 49,591,000USD |
| End Period Cash Flow | 496,304,000USD | 344,865,000USD | 358,328,000USD | 161,900,000USD | 341,246,000USD | 268,269,000USD | 187,514,000USD | 103,670,000USD |
| Other Cashflows From Financing Activities | -13,956,000USD | -5,386,000USD | -749,000USD | -649,000USD | -7,960,000USD | -11,181,000USD | -4,968,000USD | -10,323,000USD |
| Unclassified Operating Cash Flow | -22,845,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | 22,661,000USD | 32,400,000USD | — | — | — | 11,181,000USD | 4,968,000USD | 10,323,000USD |
| Unclassified Investing Cash Flow | — | 4,238,000USD | -88,201,000USD | 52,979,000USD | — | — | -1,431,000USD | 10,323,000USD |
| Other Cashflows From Investing Activities | — | — | 100,000,000USD | — | — | — | 1,431,000USD | -8,089,000USD |
| Change To Liabilities | — | — | — | -1,254,000USD | 712,000USD | 3,088,000USD | -1,014,000USD | 112,000USD |
| Sale Purchase Of Stock | — | — | — | — | 355,645,000USD | 118,019,000USD | 107,525,000USD | 73,847,000USD |
| Cash And Cash Equivalents Changes | — | — | — | — | 72,977,000USD | 80,755,000USD | 83,844,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| Q2 2026Quarterly · 2026-06-30 | Geography | Europe | 19,283,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | Japan | 8,306,000 | USD | Disclosure |
| Q2 2026Quarterly · 2026-06-30 | Geography | United States | 91,633,000 | USD | Disclosure |
| Q1 2026Quarterly · 2026-03-31 | Geography | Europe | 20,677,000 | USD | 0001711279-26-000043 |
| Q1 2026Quarterly · 2026-03-31 | Geography | Japan | 8,191,000 | USD | 0001711279-26-000043 |
| Q1 2026Quarterly · 2026-03-31 | Geography | United States | 87,489,000 | USD | 0001711279-26-000043 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Europe | 0 | USD | 0001711279-26-000043 |
| Q1 2025Quarterly · 2025-03-31 | Geography | Japan | 0 | USD | 0001711279-26-000043 |
| Q1 2025Quarterly · 2025-03-31 | Geography | United States | 88,183,000 | USD | 0001711279-26-000043 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.